These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11586492)

  • 1. Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria.
    Nakamura T; Ushiyama C; Osada S; Hara M; Shimada N; Koide H
    Metabolism; 2001 Oct; 50(10):1193-6. PubMed ID: 11586492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients.
    Nakamura T; Ushiyama C; Shimada N; Hayashi K; Ebihara I; Koide H
    J Diabetes Complications; 2000; 14(5):250-4. PubMed ID: 11113686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentrations in Type 2 diabetic patients with microalbuminuria or macroalbuminuria.
    Nakamura T; Ushiyama C; Suzuki S; Shimada N; Sekizuka K; Ebihara L; Koide H
    Diabet Med; 2001 Apr; 18(4):308-13. PubMed ID: 11437862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pioglitazone on carotid intima-media thickness and arterial stiffness in type 2 diabetic nephropathy patients.
    Nakamura T; Matsuda T; Kawagoe Y; Ogawa H; Takahashi Y; Sekizuka K; Koide H
    Metabolism; 2004 Oct; 53(10):1382-6. PubMed ID: 15375799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone reduces urinary albumin excretion in renin-angiotensin system inhibitor-treated type 2 diabetic patients with hypertension and microalbuminuria: the APRIME study.
    Morikawa A; Ishizeki K; Iwashima Y; Yokoyama H; Muto E; Oshima E; Sekiguchi M; Miura T; Itoh H; Haneda M
    Clin Exp Nephrol; 2011 Dec; 15(6):848-53. PubMed ID: 21823043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocyte as a potential target of inflammation: role of pioglitazone hydrochloride in patients with type 2 diabetes.
    Xing Y; Ye S; Hu Y; Chen Y
    Endocr Pract; 2012; 18(4):493-8. PubMed ID: 22441004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pioglitazone on urinary liver-type fatty acid-binding protein concentrations in diabetes patients with microalbuminuria.
    Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Koide H
    Diabetes Metab Res Rev; 2006; 22(5):385-9. PubMed ID: 16506273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of podocytes in patients with diabetic nephropathy.
    Nakamura T; Ushiyama C; Suzuki S; Hara M; Shimada N; Ebihara I; Koide H
    Nephrol Dial Transplant; 2000 Sep; 15(9):1379-83. PubMed ID: 10978394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.
    Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Osada S; Koide H
    Diabetes Care; 2005 Nov; 28(11):2728-32. PubMed ID: 16249547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antidiabetic medications on microalbuminuria in patients with type 2 diabetes.
    Yanagawa T; Araki A; Sasamoto K; Shirabe S; Yamanouchi T
    Metabolism; 2004 Mar; 53(3):353-7. PubMed ID: 15015149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the antiplatelet drug dilazep dihydrochloride on urinary podocytes in patients in the early stage of diabetic nephropathy.
    Nakamura T; Ushiyama C; Shimada N; Sekizuka K; Ebihara I; Hara M; Koide H
    Diabetes Care; 2000 Aug; 23(8):1168-71. PubMed ID: 10937516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Urinary albumin excretion by patients with type 2 diabetes mellitus. Effect of blood pressure and metabolic regulation].
    Jungmann E; Carlberg C; Schallmayer M; Schumm-Draeger PM
    Med Klin (Munich); 1995 Jul; 90(7):383-9. PubMed ID: 7675002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy.
    Imano E; Kanda T; Nakatani Y; Nishida T; Arai K; Motomura M; Kajimoto Y; Yamasaki Y; Hori M
    Diabetes Care; 1998 Dec; 21(12):2135-9. PubMed ID: 9839106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Canagliflozin on Urinary Albumin Excretion in Japanese Patients with Type 2 Diabetes Mellitus and Microalbuminuria: A Pilot Study.
    Osonoi T; Gouda M; Kubo M; Arakawa K; Hashimoto T; Abe M
    Diabetes Technol Ther; 2018 Oct; 20(10):681-688. PubMed ID: 30096243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms.
    Okada T; Wada J; Hida K; Eguchi J; Hashimoto I; Baba M; Yasuhara A; Shikata K; Makino H
    Diabetes; 2006 Jun; 55(6):1666-77. PubMed ID: 16731829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
    Katavetin P; Eiam-Ong S; Suwanwalaikorn S
    J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocyturia parallels proximal tubule dysfunction in type 2 diabetes mellitus patients independently of albuminuria and renal function decline: A cross-sectional study.
    Petrica L; Vlad M; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Popescu R; Gluhovschi C; Matusz P; Velciov S; Bob F; Ursoniu S; Vlad D
    J Diabetes Complications; 2017 Sep; 31(9):1444-1450. PubMed ID: 28161386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The short-term effect of a switch from glibenclamide to metformin on blood pressure and microalbuminuria in patients with type 2 diabetes mellitus.
    Amador-Licona N; Guízar-Mendoza J; Vargas E; Sánchez-Camargo G; Zamora-Mata L
    Arch Med Res; 2000; 31(6):571-5. PubMed ID: 11257323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.
    Rosenblatt S; Miskin B; Glazer NB; Prince MJ; Robertson KE;
    Coron Artery Dis; 2001 Aug; 12(5):413-23. PubMed ID: 11491207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of ibudilast on urinary albumin excretion in type 2 diabetes mellitus with microalbuminuria.
    Hoshino T; Ikeda T
    Nephron; 2002 Feb; 90(2):154-7. PubMed ID: 11818699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.